The Role of Multimodality Cardiac Imaging in the Transplanted Heart

Heart transplantation (HT) is an established life-saving treatment option for patients with end-stage heart failure. Despite many advances in the field, the development of acute cellular rejection (ACR) and cardiac allograft vasculopathy (CAV) represent significant causes of 1- and 5-year morbidity...

Full description

Saved in:
Bibliographic Details
Published inJACC. Cardiovascular imaging Vol. 2; no. 9; pp. 1126 - 1140
Main Authors Estep, Jerry D., MD, Shah, Dipan J., MD, Nagueh, Sherif F., MD, Mahmarian, John J., MD, Torre-Amione, Guillermo, MD, PhD, Zoghbi, William A., MD
Format Journal Article
LanguageEnglish
Published United States 01.09.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Heart transplantation (HT) is an established life-saving treatment option for patients with end-stage heart failure. Despite many advances in the field, the development of acute cellular rejection (ACR) and cardiac allograft vasculopathy (CAV) represent significant causes of 1- and 5-year morbidity and mortality, respectively. The search for noninvasive techniques to assess cardiac allograft function and detect treatable ACR and CAV remains a priority objective for heart transplant professionals. In this review we will: 1) highlight the clinical significance of ACR and CAV in adult cardiac transplant recipients and 2) discuss how different noninvasive imaging modalities (echocardiography, cardiac computed tomography, myocardial perfusion imaging, and cardiac magnetic resonance) have been used in the evaluation of these clinical challenges after HT.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1936-878X
1876-7591
DOI:10.1016/j.jcmg.2009.06.006